Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 18;10(2):341.
doi: 10.3390/jcm10020341.

Lights and Shadows in Hepatic Encephalopathy Diagnosis

Affiliations
Review

Lights and Shadows in Hepatic Encephalopathy Diagnosis

Piero Amodio et al. J Clin Med. .

Abstract

Hepatic encephalopathy (HE) is a form of brain dysfunction that is caused by liver insufficiency and/or portal-systemic shunting. The exact nature of HE is debated; as such, conflicting uses of the term "HE" may cause inconsistencies in its detection and management. This review highlights the meaning of the term "HE" on the basis of its historical origins and current consensus. It also provides criteria for the diagnosis of the condition based on its phenotypes and risk factors for its occurrence. The procedure for differential diagnosis from other conditions which result in similar phenotypes is considered, together with precipitants and confounders. Finally, the current multidimensional approach for the correct clinical reporting of HE episodes is discussed.

Keywords: cirrhosis; coma; delirium; encephalopathy; liver failure.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schema showing the different concepts of precipitants and confounders.
Figure 2
Figure 2
Flow chart for the diagnosis of hepatic encephalopathy (HE) (modified from [50]). ART: ammonia-reducing treatment (non-absorbable antibiotic ± disaccharides). * Low ammonia is considered to have high negative predictive value for HE [8], since it suggests: (1) relatively good liver function, (2) negligible portal-systemic shunting, and (3) negligible gut dysbiosis in cirrhosis.

References

    1. Bustamante J., Rimola A., Ventura P.J., Navasa M., Cirera I., Reggiardo V., Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J. Hepatol. 1999;30:890–895. doi: 10.1016/S0168-8278(99)80144-5. - DOI - PubMed
    1. Cardoso F.S., Gottfried M., Tujios S., Olson J.C., Karvellas C.J. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–720. doi: 10.1002/hep.29488. - DOI - PMC - PubMed
    1. Montagnese S., Bajaj J.S. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. Drugs. 2019;79:11–16. doi: 10.1007/s40265-018-1019-y. - DOI - PMC - PubMed
    1. Neff G.W., Kemmer N., Duncan C., Alsina A. Update on the management of cirrhosis—focus on cost-effective preventative strategies. Clinicoecon. Outcomes Res. 2013;5:143–152. doi: 10.2147/CEOR.S30675. - DOI - PMC - PubMed
    1. Di Pascoli M., Ceranto E., De Nardi P., Donato D., Gatta A., Angeli P., Pontisso P. Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report. Dig. Dis. 2017;35:433–438. doi: 10.1159/000458722. - DOI - PubMed

LinkOut - more resources